Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects
- PMID: 21234090
- PMCID: PMC2145121
Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects
Abstract
Gastrointestinal, renal, hepatic, and hematological adverse effects are all associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs). Some patients are particularly at risk for such problems. Preventive measures and recommendations for managing and monitoring high-risk patients are presented. Patients receiving long-term NSAID therapy should be carefully monitored.
Similar articles
-
Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.Gut. 2020 Apr;69(4):617-629. doi: 10.1136/gutjnl-2019-319300. Epub 2020 Jan 14. Gut. 2020. PMID: 31937550
-
Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.Drug Saf. 1993 Feb;8(2):99-127. doi: 10.2165/00002018-199308020-00002. Drug Saf. 1993. PMID: 8452660 Review.
-
The attitudes of owners and veterinary professionals in the United Kingdom to the risk of adverse events associated with using non-steroidal anti-inflammatory drugs (NSAIDs) to treat dogs with osteoarthritis.Prev Vet Med. 2016 Sep 1;131:121-126. doi: 10.1016/j.prevetmed.2016.07.017. Epub 2016 Aug 1. Prev Vet Med. 2016. PMID: 27544261 Free PMC article.
-
Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.Prescrire Int. 2011 Sep;20(119):216-9. Prescrire Int. 2011. PMID: 21954519 Review.
-
NSAID-related adverse drug interactions with clinical relevance. An update.Int J Clin Pharmacol Ther. 1994 Oct;32(10):509-32. Int J Clin Pharmacol Ther. 1994. PMID: 7834159 Review.
References
LinkOut - more resources
Full Text Sources